Advertisement
Screener

DEXCOM, INC. (DXCM) ROE

DEXCOM INC ROE

Return on equity (ROE) is the profit a company earns for every dollar of shareholder money invested in it, shown as a percentage. It is net income divided by shareholder equity, and the table shows both amounts: the profit earned and the equity it was earned on. A higher ROE means more profit per dollar of equity, but ROE also rises when equity shrinks through buybacks, dividends or losses, and it has no meaning for a company with negative equity. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.

  • DEXCOM INC roe for the quarter ending 2024-12-31 was 27.40%, a 4.69% increase year-over-year.
  • DEXCOM INC roe for the quarter ending 2024-06-30 was 27.40%, a 60.96% increase year-over-year.
  • DEXCOM INC roe for the quarter ending 2024-03-31 was 28.45%, a 117.22% increase year-over-year.
  • DEXCOM INC roe for the quarter ending 2023-12-31 was 26.18%, a 63.55% increase year-over-year.
  • DEXCOM INC roe for fiscal 2024 was 27.40%, a 4.69% increase from fiscal 2023.
  • DEXCOM INC roe for fiscal 2023 was 26.18%, a 63.55% increase from fiscal 2022.
  • DEXCOM INC roe for fiscal 2022 was 16.01%.
  • DEXCOM INC roe for fiscal 2020 was 30.10%, a 162.74% increase from fiscal 2019.
Available history
2009-12-31 to 2024-12-31
Data captured

Historical ROE

DateROENet income 12 monthNet income 3 monthShareholder equity
2024-12-3127.40%$576.2M$151.70M$2.1B
2024-06-3027.40%$666.9M$143.50M$2.43B
2024-03-3128.45%$639.3M$146.40M$2.25B
2023-12-3126.18%$541.5M$256.30M$2.07B
2023-09-3016.62%$377M$120.70M$2.27B
2023-06-3017.02%$357.5M$115.90M$2.1B
2023-03-3113.10%$292.5M$48.60M$2.23B
2022-12-3116.01%$341.2M$91.80M$2.13B
2022-09-3013.38%$244.1M$101.20M$1.82B
2022-06-3010.20%$230.2M$50.90M$2.26B
2022-03-3111.77%$257.7M$97.30M$2.19B
2021-12-3110.62%$216.9M-$5.30M$2.04B
2021-09-3029.66%$633.5M$87.30M$2.14B
2021-06-3030.96%$618.4M$78.40M$2B
2021-03-3130.81%$586.3M$56.50M$1.9B
2020-12-3130.10%$549.7M$411.30M$1.83B
2020-09-3015.41%$231.1M$72.20M$1.5B
2020-06-3015.12%$204.7M$46.30M$1.35B
2020-03-3115.83%$147.9M$19.90M$934.5M
2019-12-3111.45%$101.1M$92.70M$882.6M
2019-09-30-22.41%-$171.3M$45.80M$764.3M
2019-06-30-24.77%-$170.5M-$10.50M$688.3M
2019-03-31-19.41%-$129.8M-$26.90M$668.6M
2018-12-31-19.16%-$127.1M-$179.70M$663.3M
2018-09-307.68%$43.2M$46.60M$562.2M
2018-06-30-1.12%-$5.4M$30.20M$482.1M
2018-03-31-7.75%-$32.7M-$24.20M$421.7M
2017-12-31-11.97%-$50.2M-$9.40M$419.4M
2017-09-30-12.55%-$48.2M-$2.00M$384M
2017-06-30-18.38%-$65M$2.90M$353.7M
2017-03-31-31.71%-$88.1M-$41.70M$277.8M
2016-12-31-23.11%-$65.6M-$7.40M$283.8M
2016-09-30-21.66%-$56.7M-$18.80M$261.8M
2016-06-30-32.63%-$80.4M-$20.20M$246.4M
2016-03-31-27.64%-$63.9M-$19.20M$231.2M
2015-12-31-26.04%-$57.6M$1.50M$221.2M
2015-09-30-29.90%-$57.8M-$42.50M$193.3M
2015-06-30-12.01%-$20.5M-$3.70M$170.7M
2015-03-31-15.34%-$22.8M-$12.90M$148.6M
2014-12-31-15.98%-$22.4M$1.30M$140.2M
2014-09-30-22.87%-$26.3M-$5.20M$115M
2014-06-30-27.21%-$27.1M-$6.00M$99.6M
2014-03-31-34.67%-$31.2M-$12.50M$90M
2013-12-31-35.43%-$29.8M-$2.60M$84.1M
2013-09-30-47.79%-$35.7M-$6.00M$74.7M
2013-06-30-65.01%-$47M-$10.10M$72.3M
2013-03-31-70.11%-$51.6M-$11.10M$73.6M
2012-12-31-70.91%-$54.6M-$8.50M$77M
2012-09-30-72.65%-$58.31M-$17.30M$80.25M
2012-06-30-59.45%-$54.28M-$14.70M$91.31M
2012-03-31-47.16%-$46.95M-$14.10M$99.55M
2011-12-31-42.78%-$44.7M-$12.20M$104.5M
2011-09-30-37.44%-$42.34M-$13.30M$113.07M
2011-06-30-34.92%-$42.46M-$7.40M$121.58M

Annual ROE

DateROENet income 12 monthShareholder equity
2024-12-3127.40%$576.2M$2.1B
2023-12-3126.18%$541.5M$2.07B
2022-12-3116.01%$341.2M$2.13B
2020-12-3130.10%$549.7M$1.83B
2019-12-3111.45%$101.1M$882.6M
2018-12-31-19.16%-$127.1M$663.3M
2017-12-31-11.97%-$50.2M$419.4M
2016-12-31-23.11%-$65.6M$283.8M
2015-12-31-26.04%-$57.6M$221.2M
2014-12-31-15.98%-$22.4M$140.2M
2013-12-31-35.43%-$29.8M$84.1M
2012-12-31-70.78%-$54.5M$77M
2011-12-31-42.78%-$44.7M$104.5M
2010-12-31-90.49%-$55.2M$61M
2009-12-31290.89%-$53.52M-$18.4M

Similar stocks

Stock NameCountryMarket CapPE Ratio
WEST PHARMACEUTICAL SERVICES INC (WST)United States$26.288B43.14
BECTON DICKINSON & CO (BDX)United States$48.834B43.79
Solventum Corp (SOLV)United States$15.085B9.16
Penumbra Inc (PEN)United States$12.596B77.33
BAXTER INTERNATIONAL INC (BAX)United States$12.139B-10.35
GLOBUS MEDICAL INC (GMED)United States$9.977B20.03
INSULET CORP (PODD)United States$9.420B28.12
GLAUKOS Corp (GKOS)United States$9.135B-43.73
MiniMed Group, Inc. (MMED)United States$5.748B-16.85
MERIT MEDICAL SYSTEMS INC (MMSI)United States$5.212B28.44